Literature DB >> 7911393

Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behavior.

D M Yurek1, S B Hipkens.   

Abstract

The selective D1 receptor antagonist, SCH 23390, was injected into the pars reticulata region of the lesioned substantia nigra at various concentrations (3.0, 1.5, 1.0, 0.6 or 0.3 mM) just before a s.c. injection of either the selective D1 agonist, SKF 82958; the selective D2 agonist, quinpirole; or the mixed D1-D2 receptor agonist, apomorphine. SCH 23390 pretreatment (1) had no significant effect on quinpirole rotational behavior, (2) attenuated apomorphine rotational behavior and (3) dose-dependently inhibited SKF 82958 rotational behavior with the highest SCH 23390 doses completely blocking SKF 82958 rotational behavior in some animals. These data provide further evidence that dopamine release in the midbrain may act as a neuromodulator of motor behavior, and that D1 receptors play a functional role in this process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911393     DOI: 10.1016/0006-8993(94)91748-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Independent mediation of unconditioned motor behavior by striatal D1 and D2 receptors in rats depleted of dopamine as neonates.

Authors:  J P Bruno; E M Byrnes; B J Johnson
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

2.  The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.

Authors:  Edward G Meloni; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

3.  Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment.

Authors:  Trevor Archer; Tomas Palomo; Robert McArthur; Anders Fredriksson
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.